miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/NCI
Grant: R01 CA197865
NIH/NCI
Grant: CA229869
National Institute of Health
Grant: R01 CA197865 and R01 CA229869
NCI NIH HHS
Grant: R01 CA229869
National Institutes of Health
Grant: 5R01CA229869-02
Small RNAs in Breast Cancer Metastasis
National Institutes of Health
Grant: 5R01CA197865-02
Role of MED1 in HER2-driven Breast Tumorigenesis
FWCI
1.97
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals